These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26910590)

  • 1. Daptomycin for Children in Clinical Practice Experience.
    Garazzino S; Castagnola E; Di Gangi M; Ortolano R; Krzysztofiak A; Nocerino A; Esposito S; D'Argenio P; Galli L; Losurdo G; Calitri C; Tovo PA;
    Pediatr Infect Dis J; 2016 Jun; 35(6):639-41. PubMed ID: 26910590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents.
    Syriopoulou V; Dailiana Z; Dmitriy N; Utili R; Pathan R; Hamed K
    Pediatr Infect Dis J; 2016 May; 35(5):511-6. PubMed ID: 26849158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early experience with high-dosage daptomycin for prosthetic infections.
    De Rosa FG; Mollaretti O; Cometto C; Pagani N; Montrucchio C; Di Perri G
    Clin Infect Dis; 2009 Dec; 49(11):1772-3. PubMed ID: 19891570
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program.
    Figueroa DA; Mangini E; Amodio-Groton M; Vardianos B; Melchert A; Fana C; Wehbeh W; Urban CM; Segal-Maurer S
    Clin Infect Dis; 2009 Jul; 49(2):177-80. PubMed ID: 19500039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin Use in Children: Experience With Various Types of Infection and Age Groups.
    Syrogiannopoulos GA; Michoula AN; Petinaki E; Grivea IN
    Pediatr Infect Dis J; 2017 Oct; 36(10):962-966. PubMed ID: 28471867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin in paediatrics: current knowledge and the need for future research.
    Principi N; Caironi M; Venturini F; Pani L; Esposito S
    J Antimicrob Chemother; 2015 Mar; 70(3):643-8. PubMed ID: 25406298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study.
    Shrestha NK; Mason P; Gordon SM; Neuner E; Nutter B; O'Rourke C; Rehm SJ
    J Antimicrob Chemother; 2014 May; 69(5):1407-15. PubMed ID: 24398341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Daptomycin in Critically Ill Children With Bloodstream Infections and Complicated Skin and Soft-tissue Infections.
    Tedeschi S; Tumietto F; Conti M; Giannella M; Viale P;
    Pediatr Infect Dis J; 2016 Feb; 35(2):180-2. PubMed ID: 26484430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of high-dose daptomycin (>6 mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram-positive bacteria.
    Perrottet N; Steinrücken J; Chan M; Pannatier A; Borens O; Yusuf E; Trampuz A
    Int J Antimicrob Agents; 2015 Oct; 46(4):480-2. PubMed ID: 26235888
    [No Abstract]   [Full Text] [Related]  

  • 10. Daptomycin experience in patients with human immunodeficiency virus and resistant gram-positive infections.
    Slim J; Jimenez H; Culshaw D; Patel H; Lamp KC
    J Int Assoc Provid AIDS Care; 2015; 14(3):202-6. PubMed ID: 25320146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin: evaluation of a high-dose treatment strategy.
    Wu G; Abraham T; Rapp J; Vastey F; Saad N; Balmir E
    Int J Antimicrob Agents; 2011 Sep; 38(3):192-6. PubMed ID: 21549573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections.
    Lai CC; Sheng WH; Wang JT; Liao CH; Ho MW; Chen CJ; Chen DL; Chou MU; Lee CM; Lin YC; Pong MY; Chang SC
    J Microbiol Immunol Infect; 2012 Feb; 45(1):52-7. PubMed ID: 22153759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of daptomycin in patients completing more than 14 days of therapy: results from the Cubicin® Outcomes Registry and experience.
    Rege S; Mohr J; Lamp KC; Yoon M; Lindfield KC
    Int J Antimicrob Agents; 2013 May; 41(5):421-5. PubMed ID: 23394685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin for outpatient parenteral antibiotic therapy: a European registry experience.
    Seaton RA; Gonzalez-Ramallo VJ; Prisco V; Marcano-Lozada M; Gonzalez-Ruiz A; Gallegos B; Menichetti F; Loeffler J; Bouylout K; Chaves RL
    Int J Antimicrob Agents; 2013 May; 41(5):468-72. PubMed ID: 23473943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.
    Abdel-Rahman SM; Benziger DP; Jacobs RF; Jafri HS; Hong EF; Kearns GL
    Pediatr Infect Dis J; 2008 Apr; 27(4):330-4. PubMed ID: 18316988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of daptomycin in patients receiving hemodialysis.
    Mueller BA; Crompton JA; Donovan BJ; Yankalev S; Lamp KC
    Pharmacotherapy; 2011 Jul; 31(7):665-72. PubMed ID: 21923453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and effectiveness of daptomycin across a hospitalized obese population: results of a multicenter investigation in the southeastern United States.
    Bookstaver PB; Bland CM; Qureshi ZP; Faulkner-Fennell CM; Sheldon MA; Caulder CR; Hartis C;
    Pharmacotherapy; 2013 Dec; 33(12):1322-30. PubMed ID: 23712701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved Gram-positive infections.
    Abdel-Rahman SM; Chandorkar G; Akins RL; Bradley JS; Jacobs RF; Donovan J; Benziger DP
    Pediatr Infect Dis J; 2011 Aug; 30(8):712-4. PubMed ID: 21317681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin experience in critical care patients: results from a registry.
    Brown JE; Fominaya C; Christensen KJ; McConnell SA; Lamp KC
    Ann Pharmacother; 2012 Apr; 46(4):495-502. PubMed ID: 22454446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.